Logo Image
News
OncClubAll Oncology NewsClinical Trials in Focus
Watch
Expert ConversationsShows & PodcastsNews & Analysis
Conferences
Conference CoverageConference Listing
Events
Giants of Cancer CareCME/CEScientific InterchangesState of the Science SummitNational Fellows ForumWebinars
More
Partners
Publications
All PublicationsSupplements
Resources
Consensus ViewpointsOncLive AppInteractive ToolsSponsored
Biomarker Consortium

Subscribe

  • News
  • Watch
  • Conferences
  • Events
  • Partners
  • Publications
  • Resources
  • Biomarker Consortium
  • Subscribe
  • AI for Oncology
  • Biosimilars
  • Brain Cancer
  • Breast Cancer
    • HER2+ Breast Cancer
  • CAR T-Cell Therapy
  • Disparities in Cancer Care
  • Gastrointestinal Cancer
    • Pancreatic Cancer
    • Hepatocellular Carcinoma
    • Gastric Cancer
    • Colorectal Cancer
  • Genitourinary Cancers
    • Urothelial Cancer
    • Prostate Cancer
  • Global Oncology
  • Graft-vs-Host Disease
  • Gynecologic Oncology
    • Ovarian Cancer
  • Head & Neck Cancers
  • Hematologic Oncology
    • Chronic Lymphocytic Leukemia
    • Non-Hodgkin Lymphoma
    • Mantle Cell Lymphoma
    • Multiple Myeloma
    • Myeloproliferative Neoplasms
  • Immuno-Oncology
  • Lung Cancer
  • Melanoma & Skin Cancer
  • Oncology Business Management
  • Pediatric Oncology
  • Precision Medicine in Oncology®
  • Sarcomas
  • Supportive Care
Spotlight -
The OncLive Insider app is live!|
CME Opportunities
Advertisement

Laurel A. Menapace, MD

Advertisement

Articles by Laurel A. Menapace, MD

Challenging Case Teaches Oncology Fellow the Power of Hope

ByLaurel A. Menapace, MD
October 30th 2017

Advanced esophageal cancer is a highly lethal malignancy and often spreads despite aggressive therapy.

Advertisement

Latest Updated Articles

  • Challenging Case Teaches Oncology Fellow the Power of Hope
    Challenging Case Teaches Oncology Fellow the Power of Hope

    October 30th 2017



Advertisement
Advertisement

Trending on OncLive

1

ASCO Guideline Update Broadens First-Line Treatment Options for HER2+ Gastroesophageal Cancer

2

CAR T-Cell Therapy Continues to Make Its Case in Early Relapsed Myeloma

3

FDA Awards Fast Track Designation to Safusidenib in IDH1-Mutant Glioma

4

European Commission Approves Teclistamab Plus Daratumumab for R/R Myeloma

5

ASCO Issues First Guideline on ctDNA Testing in Solid Tumors and Lymphoma

  • Advertise
  • About OncLive
  • Editorial Board
  • MJH Life Sciences brands
  • Contact Us
  • Privacy
  • Terms & Conditions
  • Do Not Sell My Information
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

Brand Logo
Download on Apple
Download on Google Play

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us